These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36604493)

  • 1. Single-cell-led drug repurposing for Alzheimer's disease.
    Parolo S; Mariotti F; Bora P; Carboni L; Domenici E
    Sci Rep; 2023 Jan; 13(1):222. PubMed ID: 36604493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug repositioning targeting glutaminase reveals drug candidates for the treatment of Alzheimer's disease patients.
    Bayraktar A; Li X; Kim W; Zhang C; Turkez H; Shoaie S; Mardinoglu A
    J Transl Med; 2023 May; 21(1):332. PubMed ID: 37210557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering molecular bridges: Unveiling the interplay between metabolic syndrome and Alzheimer's disease through a systems biology approach and drug repurposing.
    Azizan Z; Zali H; Mirmotalebisohi SA; Bazrgar M; Ahmadiani A
    PLoS One; 2024; 19(5):e0304410. PubMed ID: 38809924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropathological stage-dependent proteome mapping of the olfactory tract in Alzheimer's disease: From early olfactory-related omics signatures to computational repurposing of drug candidates.
    Cartas-Cejudo P; Cortés A; Lachén-Montes M; Anaya-Cubero E; Puerta E; Solas M; Fernández-Irigoyen J; Santamaría E
    Brain Pathol; 2024 Jul; 34(4):e13252. PubMed ID: 38454090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.
    Zhou Y; Fang J; Bekris LM; Kim YH; Pieper AA; Leverenz JB; Cummings J; Cheng F
    Alzheimers Res Ther; 2021 Jan; 13(1):24. PubMed ID: 33441136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
    Shoaib M; Kamal MA; Rizvi SMD
    Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repurposing on Alzheimer's disease through modulation of NRF2 neighborhood.
    Bourdakou MM; Fernández-Ginés R; Cuadrado A; Spyrou GM
    Redox Biol; 2023 Nov; 67():102881. PubMed ID: 37696195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinational Drug Repurposing from Genetic Networks Applied to Alzheimer's Disease.
    Nabirotchkin S; Bouaziz J; Glibert F; Mandel J; Foucquier J; Hajj R; Callizot N; Cholet N; Guedj M; Cohen D
    J Alzheimers Dis; 2022; 88(4):1585-1603. PubMed ID: 35811522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical genetics-based drug repurposing for Alzheimer's disease.
    Zhang XZ; Quan Y; Tang GY
    Brain Res Bull; 2015 Jan; 110():26-9. PubMed ID: 25446738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Repurposing for Alzheimer's Disease Based on Protein-Protein Interaction Network.
    Soleimani Zakeri NS; Pashazadeh S; MotieGhader H
    Biomed Res Int; 2021; 2021():1280237. PubMed ID: 34692825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Functional Pipeline of Genome-Wide Association Data Leads to Midostaurin as a Repurposed Drug for Alzheimer's Disease.
    Esteban-Martos A; Brokate-Llanos AM; Real LM; Melgar-Locatelli S; de Rojas I; Castro-Zavala A; Bravo MJ; Mañas-Padilla MDC; García-González P; Ruiz-Galdon M; Pacheco-Sánchez B; Polvillo R; Rodriguez de Fonseca F; González I; Castilla-Ortega E; Muñoz MJ; Rivera P; Reyes-Engel A; Ruiz A; Royo JL
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics methods in drug repurposing for Alzheimer's disease.
    Siavelis JC; Bourdakou MM; Athanasiadis EI; Spyrou GM; Nikita KS
    Brief Bioinform; 2016 Mar; 17(2):322-35. PubMed ID: 26197808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico repurposing of antipsychotic drugs for Alzheimer's disease.
    Kumar S; Chowdhury S; Kumar S
    BMC Neurosci; 2017 Oct; 18(1):76. PubMed ID: 29078760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future avenues for Alzheimer's disease detection and therapy: liquid biopsy, intracellular signaling modulation, systems pharmacology drug discovery.
    Hampel H; Vergallo A; Caraci F; Cuello AC; Lemercier P; Vellas B; Giudici KV; Baldacci F; Hänisch B; Haberkamp M; Broich K; Nisticò R; Emanuele E; Llavero F; Zugaza JL; Lucía A; Giacobini E; Lista S;
    Neuropharmacology; 2021 Mar; 185():108081. PubMed ID: 32407924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases.
    Emon MA; Kodamullil AT; Karki R; Younesi E; Hofmann-Apitius M
    J Alzheimers Dis; 2017; 56(2):677-686. PubMed ID: 28035920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.
    Fang J; Zhang P; Wang Q; Chiang CW; Zhou Y; Hou Y; Xu J; Chen R; Zhang B; Lewis SJ; Leverenz JB; Pieper AA; Li B; Li L; Cummings J; Cheng F
    Alzheimers Res Ther; 2022 Jan; 14(1):7. PubMed ID: 35012639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic Insights for Drug Repurposing and the Design of Hybrid Drugs for Alzheimer's Disease.
    Padhi D; Govindaraju T
    J Med Chem; 2022 May; 65(10):7088-7105. PubMed ID: 35559617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning identifies candidates for drug repurposing in Alzheimer's disease.
    Rodriguez S; Hug C; Todorov P; Moret N; Boswell SA; Evans K; Zhou G; Johnson NT; Hyman BT; Sorger PK; Albers MW; Sokolov A
    Nat Commun; 2021 Feb; 12(1):1033. PubMed ID: 33589615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repurposing antihypertensive drugs for the prevention of Alzheimer's disease: a Mendelian randomization study.
    Walker VM; Kehoe PG; Martin RM; Davies NM
    Int J Epidemiol; 2020 Aug; 49(4):1132-1140. PubMed ID: 31335937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's disease master regulators analysis: search for potential molecular targets and drug repositioning candidates.
    Vargas DM; De Bastiani MA; Zimmer ER; Klamt F
    Alzheimers Res Ther; 2018 Jun; 10(1):59. PubMed ID: 29935546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.